신경학용 기기 시장 보고서 : 제품별, 최종사용자별, 지역별(2026-2034년)

The global neurology devices market size reached USD 15.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 26.8 Billion by 2034, exhibiting a growth rate (CAGR) of 6.20% during 2026-2034. There are various factors that are driving the market, which include increasing prevalence of various neurological disorders like epilepsy, Alzheimer's disease, dementias, and cerebrovascular diseases, introduction of improved devices due to technological advancements, and rising geriatric population.

NEUROLOGY DEVICES MARKET ANALYSIS:

• Major Market Drivers: One of the key market drivers is favorable government initiatives. Moreover, the expansion of healthcare facilities is acting as a growth-inducing factor.
• Key Market Trends: The market demand is propelled, owing to numerous primary trends, which include rising incidences of various neurological disorders and the increasing geriatric population.
• Geographical Trends: According to the report, North America exhibits a clear dominance, accounting for the largest market share on account of the presence of advanced healthcare facilities.
• Competitive Landscape: Some of the major market players in the neurology devices industry are Abbott, B. Braun SE, Boston Scientific Corporation, Integra LifeSciences Corporation, LivaNova PLC, Medtronic plc, Natus Medical Incorporated, Nihon Kohden Corporation, Penumbra, Inc, and Stryker Corporation, among many others.
• Challenges and Opportunities: One of the key challenges hindering the market growth are regulatory hurdles. On the other hand, advancements in regenerative medicine and restorative therapies represent recent opportunities.

NEUROLOGY DEVICES MARKET TRENDS:

Increasing Prevalence of Neurological Disorders

According to the World Health Organization (WHO), the number of people with diabetic neuropathy was 206 Million in 2021. People are suffering from numerous neurological disorders on account of genetic disorders, infections, congenital abnormalities, lifestyle health problems including malnutrition, and brain, spinal cord, and nerve injury. These diseases have a negative impact on the life of individuals like poor coordination, muscle weakness, and loss of sensation. In addition, the rising need for effective and reliable solutions among patients is catalyzing the neurology device demand. These devices enable precise diagnosis of neurological conditions by allowing detailed visualization and monitoring of brain activity and structure.

Introduction of Improved Devices Due to Technological Advancements

Key players are focusing on introducing devices that have innovative technologies and can provide enhanced care to patients. They are offering devices that have telemedicine capabilities and allow for remote monitoring of patients. For example, Abbott released a new edition of its NeuroSphere TM myPath TM digital health app on 25 April 2022. This version has more features that will allow physicians to monitor their patients more carefully. While using a dorsal root ganglion (DRG) or spinal cord stimulation (SCS) therapy device, the patient, a doctor, and their team can view patient-reported outcome measurements together on a digital health app at every point of the treatment process.

Rising Geriatric Population

The increasing number of geriatric populations across the globe is offering a positive neurology devices market outlook. Owing to their increased vulnerability to neurological conditions such as dementia, stroke, Parkinson's disease, and Alzheimer's disease, older persons are becoming more and more in need of neurology equipment. Elderly people require more medical attention, and as neurological issues are more prevalent in this age group, there is a greater need for neurology services and supplies. The World Health Organization (WHO) projects that the number of persons aged 80 years or older is expected to reach 426 Million in 2050.

NEUROLOGY DEVICES MARKET SEGMENTATION:

Breakup by Product:

• Neurostimulation Devices
• Neurosurgery Devices
• Interventional Neurology Devices
• Cerebrospinal Fluid Management Devices
• Others

Neurostimulation devices account for the majority of the market share

Neurostimulation devices play a crucial role in stimulating nerves and regulating faulty neural pathway behavior arising from the disease process by means of medication, electrical signals, or energy. They provide a customized approach to managing the patient's condition and can be adjusted to meet the needs of the individual. Neurostimulation offers an alternative that may reduce the need for medication or dosage for those who depend on it to control their symptoms. Additionally, these tools can help with focus, cognitive enhancement, better sleep, less stress, and treatment of conditions including depression, migraines, anxiety, and insomnia, which is contributing to the neurology devices market growth. Moreover, big players in the market are introducing new products and receiving money from authorities to enhance patient care. For instance, on 08 January 2024, the US FDA approved Medtronic plc's PerceptTM RC deep brain stimulation (DBS) system. The rechargeable neurostimulator is the newest member of the Medtronic PerceptTM family, which also includes the PerceptTM PC neurostimulator, BrainSenseTM technology, and SenSightTM directional leads. Individualized treatment plans can be created for patients with movement disorders such as essential tremor, dystonia, Parkinson's disease, and epilepsy using the only sensing-enabled DBS device in the PerceptTM family.

Breakup by End User:

• Hospitals
• Ambulatory Surgery Centers
• Neurology Clinics

Hospitals hold the largest share of the industry

In 2021, there were approximately 165,000 hospitals worldwide, according to DiscoveryABATherapy. Hospitals are outfitted to offer full medical care, including sophisticated neurological disorder treatments, emergency services, and advanced diagnostics. As a result, they serve as the main locations for the use of various neurology devices. Furthermore, hospitals can accommodate a greater number of patients including those with neurological disorders as compared to other types of healthcare institutions. The need for neurology equipment in these settings is driven by the increased patient influx. These facilities also feature the infrastructure required to handle advanced neurological devices, as well as specialist medical personnel like neurologists, neurosurgeons, and specialized nursing care. This includes wards designed specifically for post-operative care and monitoring and operating rooms furnished for neurosurgery procedures.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest neurology devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for neurology devices.

North America has modern medical technologies with state-of-the-art healthcare institutions. The region's medical research institutes are concentrating on research and development (R&D) endeavors, as these operations foster innovation and lead to the release of new neurological equipment onto the market. Apart from this, the market expansion is being aided by favorable government efforts in North America. Moreover, the high prevalence of neurological disorders among the North American population necessitates robust healthcare solutions. The need for neurology equipment in the region is fueled by their vital role in the management and treatment of various illnesses. As per the Alzheimer's Association, there were will be around13 Million Americans that will suffer from Alzheimer's disease by 2050.

Competitive Landscape:

Top companies in neurology devices industry are forming strategic mergers and acquisitions (M&As), partnerships, and collaborations to expand their product portfolios and geographical reach. They are creating novel and inventive products with improved efficacy and safety by investing in R&D activities. Additionally, companies are expanding their operations globally to tap into emerging markets where there is a growing awareness of neurological diseases and an increasing capability to spend on advanced medical treatments. This includes establishing production facilities or sales offices in new areas, which will also benefit in increasing their neurology devices market revenue. To remain competitive in the market, they are also launching new items and updating old ones. For instance, Abbott introduced its NeuroSphereTM Virtual Clinic in the United States on 8 March 2021. This innovative technology enables patients to interact with doctors, guarantee optimal settings and functionality, and obtain new treatment settings from a distance. Approved by the U.S. Food and Drug Administration (FDA), the NeuroSphere Virtual Clinic can increase access to optimal treatment for patients suffering from chronic pain or movement disorders.

The report provides a comprehensive analysis of the competitive landscape in the global neurology devices market with detailed profiles of all major companies, including:

• Abbott
• B. Braun SE
• Boston Scientific Corporation
• Integra LifeSciences Corporation
• LivaNova PLC
• Medtronic plc
• Natus Medical Incorporated
• Nihon Kohden Corporation
• Penumbra, Inc
• Stryker Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global neurology devices market in 2025?

2. What is the expected growth rate of the global neurology devices market during 2026-2034?

3. What are the key factors driving the global neurology devices market?

4. What has been the impact of COVID-19 on the global neurology devices market?

5. What is the breakup of the global neurology devices market based on the product?

6. What is the breakup of the global neurology devices market based on the end user?

7. What are the key regions in the global neurology devices market?

8. Who are the key players/companies in the global neurology devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Neurology Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Neurostimulation Devices
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Neurosurgery Devices
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Interventional Neurology Devices
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Cerebrospinal Fluid Management Devices
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Others
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Ambulatory Surgery Centers
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Neurology Clinics
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Abbott
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 B. Braun SE
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 SWOT Analysis
  • 13.3.3 Boston Scientific Corporation
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 Integra LifeSciences Corporation
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 LivaNova PLC
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
  • 13.3.6 Medtronic plc
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 Natus Medical Incorporated
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 Nihon Kohden Corporation
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
    • 13.3.8.4 SWOT Analysis
  • 13.3.9 Penumbra, Inc
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
  • 13.3.10 Stryker Corporation
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
    • 13.3.10.3 Financials
    • 13.3.10.4 SWOT Analysis